Shares appear to be on sale given the earlier news this week. Can't imagine a sale being much lower than $20. Earnings and revenues accelerating second half of 2016. Buyer will want to close sometime before holiday season so look for announcement before end of 2Q or very early 3Q.
BBW goes up rather nicely last week and then all of a sudden drops with some volume (so far) in trading the day before earnings are out. Insider knowledge? If earnings disappoint, I believe an investigation should commence with this selling. We will see.
There is no rational reasoning to conclude there was a denial sent out by Semarnat earlier this week. The shares would have plummeted and OMEX would have been obligated to state something in response to the decline in the share price. This seems common sense. That is not saying there was an absolute approval. My guess is there was a form of approval that requires some additional documentation therefore no statements from OMEX or anyone for that matter. Just my two cents worth but if the documentation delivered earlier this week had a denial, the shares would have already declined whether OMEX stated anything or not. Word would have certainly leaked on a denial.